We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BFX
2326
DELISTED
BowFlex Inc.
BFX
| $724K | ﹤0.01% |
46,276
-2,262
| -5% | -$48.6K |
|
2327
Replimune Group
REPL
$1.01B
| $721K | ﹤0.01% |
23,618
-1,135
| -5% | -$42.5K |
|
2328
OneSpaWorld
OSW
$2.66B
| $720K | ﹤0.01% |
67,567
-3,110
| -4% | -$31.4K |
|
|
ISEE
2329
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $718K | ﹤0.01% |
116,249
-7,250
| -6% | -$44K |
|
|
OLP
2330
One Liberty Properties
OLP
$527M
| $716K | ﹤0.01% |
32,143
-680
| -2% | -$14.7K |
|
2331
American Superconductor
AMSC
$1.59B
| $714K | ﹤0.01% |
37,643
-1,073
| -3% | -$26.6K |
|
|
MCFE
2332
DELISTED
McAfee Corp. Class A Common Stock
MCFE
| $714K | ﹤0.01% |
31,403
+7,337
| +30% | +$153K |
|
2333
Mitek Systems
MITK
$834M
| $713K | ﹤0.01% |
48,877
-3,791
| -7% | -$60.9K |
|
|
CATC
2334
DELISTED
CAMBRIDGE BANCORP
CATC
| $713K | ﹤0.01% |
8,457
-470
| -5% | -$36.8K |
|
|
CLVS
2335
DELISTED
Clovis Oncology, Inc.
CLVS
| $713K | ﹤0.01% |
101,528
-5,908
| -5% | -$39.6K |
|
2336
Vishay Precision Group
VPG
$914M
| $712K | ﹤0.01% |
23,120
-630
| -3% | -$20.9K |
|
|
ICPT
2337
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $712K | ﹤0.01% |
30,853
-1,256
| -4% | -$35K |
|
2338
Astronics
ATRO
$3.84B
| $710K | ﹤0.01% |
47,242
-2,083
| -4% | -$26.9K |
|
2339
Syndax Pharmaceuticals
SNDX
$1.82B
| $710K | ﹤0.01% |
31,768
-925
| -3% | -$20.9K |
|
|
BELFB
2340
Bel Fuse Inc Class B
BELFB
$4.21B
| $709K | ﹤0.01% |
35,638
+992
| +3% | +$17.5K |
|
2341
Annexon
ANNX
$886M
| $707K | ﹤0.01% |
25,396
+9,623
| +61% | +$265K |
|
2342
NRC Health Common Stock
NRC
$450M
| $707K | ﹤0.01% |
15,098
-1,154
| -7% | -$56.1K |
|
2343
Veritone
VERI
$122M
| $705K | ﹤0.01% |
29,403
+275
| +0.9% | +$9.81K |
|
2344
Sana Biotechnology
SANA
$980M
| $702K | ﹤0.01% |
+20,981
| New | +$683K |
|
2345
Farmers National Banc Corp
FMNB
$930M
| $700K | ﹤0.01% |
41,945
-1,440
| -3% | -$21.1K |
|
2346
Funko
FNKO
$328M
| $700K | ﹤0.01% |
35,563
-1,565
| -4% | -$21.8K |
|
2347
Hooker Furnishings Corp
HOFT
$166M
| $694K | ﹤0.01% |
19,021
-700
| -4% | -$23.9K |
|
|
ORC
2348
Orchid Island Capital
ORC
$1.31B
| $693K | ﹤0.01% |
23,066
+570
| +3% | +$16K |
|
2349
OptimizeRx
OPRX
$133M
| $690K | ﹤0.01% |
14,149
+767
| +6% | +$37K |
|
2350
Nkarta
NKTX
$172M
| $687K | ﹤0.01% |
20,870
+2,273
| +12% | +$109K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.